2013 Year in Review: OPDP Warning Letters and Untitled Letters
By EsqSocial Corporation 06/02/14
In 2013, the Center for Drug Evaluation and Research’s (CDER) Office of Prescription Drug Promotion (OPDP) issued a total of 24 enforcement letters to pharmaceutical manufacturers, four fewer than in 2012. Of the 24 letters, three were Warning...
By: King & Spalding